Matches in Nanopublications for { ?s ?p "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP398236.RARfoxXJkqcTKdhWfQwHgL9ExjAWOFinsPINmYVIses_A130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398236.RARfoxXJkqcTKdhWfQwHgL9ExjAWOFinsPINmYVIses_A130_provenance.
- assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP398153.RAioYqCJCx3TtMHjoI0g10chdL2F0kjISBFE5JTwt3M9c130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398153.RAioYqCJCx3TtMHjoI0g10chdL2F0kjISBFE5JTwt3M9c130_provenance.
- NP548757.RAhbrVL03QtLGkV2L4pj9DoxKlFRCkzHstGYlVJJfwe-s130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548757.RAhbrVL03QtLGkV2L4pj9DoxKlFRCkzHstGYlVJJfwe-s130_provenance.
- NP548758.RAOqCIco-nLgx3K9TXdHJ5pky9-0mh8GFwVLKB9eflW1M130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548758.RAOqCIco-nLgx3K9TXdHJ5pky9-0mh8GFwVLKB9eflW1M130_provenance.
- NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- NP548765.RAJdTN45DVeiZ8DvDBQ02o9G0uIQ5Q7E3mOgH1lgt1HD8130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548765.RAJdTN45DVeiZ8DvDBQ02o9G0uIQ5Q7E3mOgH1lgt1HD8130_provenance.
- NP890287.RAwcisPfXK8w2W3wUkWXKlMzMGOaMohxeLceYNIjR_SG4130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890287.RAwcisPfXK8w2W3wUkWXKlMzMGOaMohxeLceYNIjR_SG4130_provenance.